XML 45 R32.htm IDEA: XBRL DOCUMENT
v3.8.0.1

COMMITMENTS AND CONTINGENCIES (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2018
Commitments and Contingencies Disclosure [Abstract] |
Schedule of Contingent Consideration | A reconciliation of the opening balances to the closing balances of these Level 3 measurements is as follows (amounts in thousands):
Three Months Ended March 31, 2018 | Above Market Supply Agreement Liability - Short-term |  | Location in Financial Statements
Balance as of January 1, 2018 | $ | 2,641 |  |  |
Payments | (214 | ) |  |
Gain from change in fair value | (980 | ) |  | Selling, general and administrative
Transfer to accounts payable | (571 | ) |  |
Balance as of March 31, 2018 | $ | 876 |  |  |
Three Months Ended March 31, 2017 |  | Supply Agreement Liability - Short-term |  | Above Market Supply Agreement Liability - Short- Term |  | Above Market Supply Agreement Liability - Long-term |  | Location in Financial Statements
Balance as of January 1, 2017 |  | $ | 166 |  |  | $ | — |  |  | $ | 2,648 |  |  |
Payments |  | (166 | ) |  | — |  |  | (155 | ) |  |
Transfer from long-term to current portion |  | — |  |  | 1,752 |  |  | (1,752 | ) |  |
Loss from increase in fair value |  | — |  |  | — |  |  | 59 |  |  | Selling, general and administrative
Balance as of March 31, 2017 |  | $ | — |  |  | $ | 1,752 |  |  | $ | 800 |  |  |
A reconciliation of the opening balances to the closing balances of these Level 3 measurements for the three months ended March 31, 2018 and 2017 is as follows (in thousands):
Three Months Ended March 31, 2018 |  | Contingent Considerations Liabilities Related to Acquisition of Derma Sciences (See Note 2) |  | Contingent Consideration Liability Related to Acquisition of Confluent Surgical, Inc. |  | Location in Financial Statements
|  | Short-term |  | Long-term |  | Short-term |  |
Balance as of January 1, 2018 |  | $ | 315 |  |  | $ | 1,387 |  |  | $ | 22,478 |  |  |
Loss from change in fair value of contingent consideration liabilities |  | — |  |  | 32 |  |  | 1,422 |  |  | Selling, general and administrative
Balance as of March 31, 2018 |  | $ | 315 |  |  | $ | 1,419 |  |  | $ | 23,900 |  |  |
Three Months Ended March 31, 2017 |  | Contingent Considerations Liabilities Related to Acquisition of Derma Sciences (See Note 2) |  | Contingent Consideration Liability Related to Acquisition of Confluent Surgical, Inc. |  | Location in Financial Statements
|  | Short-term |  | Long-term |  | Short-term |  | Long-term |  |
Balance as of January 1, 2017 |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 22,036 |  |  |
Additions from acquisition of Derma Sciences |  | 32,848 |  |  | 3,467 |  |  | — |  |  | — |  |  |
Transfers from long-term to current portion |  | — |  |  | — |  |  | 4,198 |  |  | (4,198 | ) |  |
Loss from change in fair value of contingent consideration liabilities |  | — |  |  | 82 |  |  | — |  |  | 120 |  |  | Selling, general and administrative
Balance as of March 31, 2017 |  | $ | 32,848 |  |  | $ | 3,549 |  |  | $ | 4,198 |  |  | $ | 17,958 |  |  |

X
- References No definition available. + Details
Name: | us-gaap_CommitmentsAndContingenciesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19279-110258 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration